Page last updated: 2024-12-10

1-palmitoyl-2-oleoylphosphatidylethanolamine, (z & r)-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Palmitoyl-2-oleoylphosphatidylethanolamine (POPE)

**1-Palmitoyl-2-oleoylphosphatidylethanolamine (POPE)** is a type of phospholipid, a major component of cell membranes. It's a **zwitterionic molecule**, meaning it carries both positive and negative charges.

**Structure:**

* **1-palmitoyl:** The first fatty acid chain is palmitic acid, a saturated 16-carbon fatty acid.
* **2-oleoyl:** The second fatty acid chain is oleic acid, an unsaturated 18-carbon fatty acid with a cis double bond.
* **Phosphatidylethanolamine:** This is the backbone of the phospholipid, consisting of glycerol, a phosphate group, and ethanolamine.

**Z and R isomers:**

The z and r notation refers to the **stereoisomers** of the oleic acid moiety. The presence of a cis double bond in oleic acid creates two possible configurations:

* **Z (cis) isomer:** The hydrogen atoms on the carbons involved in the double bond are on the same side of the molecule. This is the naturally occurring isomer.
* **R (trans) isomer:** The hydrogen atoms on the carbons involved in the double bond are on opposite sides of the molecule.

**Importance in research:**

POPE, particularly the **Z isomer**, is a very important molecule in research for various reasons:

* **Model membrane studies:** POPE is a key component of **model membranes**, such as liposomes and vesicles, which are used to study membrane properties and interactions with other molecules. Its structure allows it to form stable bilayers, mimicking the structure of biological membranes.
* **Lipid-protein interactions:** POPE plays a crucial role in lipid-protein interactions. It can form **complexes with proteins**, affecting their function and localization.
* **Drug delivery:** Liposomes made of POPE are used as **drug delivery systems**. They encapsulate drugs and deliver them to specific targets in the body.
* **Understanding membrane dynamics:** POPE's unique properties allow researchers to study **membrane fluidity, phase transitions, and other dynamic aspects** of cell membranes.
* **Nanotechnology:** POPE is also used in the development of **nanomaterials** and **biosensors**, taking advantage of its amphiphilic nature and ability to interact with various molecules.

**In summary:**

POPE is a crucial molecule in research, particularly in the fields of membrane biology, drug delivery, and nanotechnology. Its specific structure and properties make it an ideal model system for understanding membrane function and developing novel therapeutic strategies.

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine : A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5283496
CHEBI ID73124
CHEBI ID34083
SCHEMBL ID234578
MeSH IDM0323897

Synonyms (33)

Synonym
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
LMGP02010009
pe(16:0/18:1(9z))
1-hexadecanoyl-2-(9z-octadecenoyl)-sn-glycero-3-phosphoethanolamine
1-16:0-2-18:1-phosphatidylethanolamine
16:0-18:1-pe
pe 34:1
[(2r)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (z)-octadec-9-enoate
gpe(34:1)
CHEBI:73124
gpe(16:0/18:1)
1-palmitoyl-2-oleoyl-gpe
pe(16:0/18:1omega9)
1-hexadecanoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
gpetn(16:0/18:1omega9)
(19r)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22lambda(5)-phosphapentacosan-19-yl (9z)-octadec-9-enoate
phosphatidylethanolamine(16:0/18:1omega9)
(r)-1-((((2-aminoethoxy)hydroxyphosphinyl)oxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl oleate
vm33lru3a6 ,
26662-94-2
einecs 247-894-0
unii-vm33lru3a6
SCHEMBL234578
[(2~{r})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{z})-octadec-9-enoate
J-016509
{1-hexadecanoyl-2-[(z)-octadec-9-enoyl]-sn-glycero-3-phospho}ethanolamine
CHEBI:34083
Q27889340
mfcd00672608
2-oleoyl-1-palmitoyl-sn-glycero-3-phosphoethanolamine (pope)
(2r,9z)-1-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-3-(palmitoyloxy)propan-2-yl oleate
DTXSID401212159
F77444
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
phosphatidylethanolamineA class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxy group of ethanolamine.
1,2-diacyl-sn-glycero-3-phosphoethanolamineAn optically active form of phosphatidylethanolamine having R-configuration.
phosphatidylethanolamine 34:1 zwitterionA 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 34 carbons in total with 1 double bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (32)

PathwayProteinsCompounds
phospholipid biosynthesis CL(16:0/14:0/18:1(9Z)/14:0)1120
phospholipid biosynthesis CL(16:0/16:0/16:0/18:1(9Z))1122
phospholipid biosynthesis CL(16:0/16:0/18:1(9Z)/16:0)1122
phospholipid biosynthesis CL(16:0/16:1(9Z)/16:1(9Z)/18:1(9Z))1324
phospholipid biosynthesis CL(16:0/16:1(9Z)/18:1(9Z)/16:1(9Z))1324
phospholipid biosynthesis CL(16:0/18:1(9Z)/14:0/14:0)1120
phospholipid biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z))1324
phospholipid biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z))1121
phospholipid biosynthesis CL(16:1(9Z)/16:0/16:1(9Z)/18:1(9Z))1324
phospholipid biosynthesis CL(16:1(9Z)/16:0/18:1(9Z)/16:1(9Z))1324
phospholipid biosynthesis CL(16:1(9Z)/16:1(9Z)/18:1(9Z)/16:0)1324
Phosphatidylcholine biosynthesis PC(16:0/18:1(9Z))27
Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z))620
Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z))516
Phosphatidylcholine/Phosphatidylethanolamine Biosynthesis PC(16:0/18:1(9Z)) | PE(16:0/18:1(9Z))617
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/14:0)324
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/16:0)324
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/14:0/18:1(9Z))323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/14:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/17:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z))325
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:0/19:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/16:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/16:1(9Z)/18:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/16:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/17:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/17:0cycw7/18:1(9Z))323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/14:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:0)327
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/16:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/17:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/18:1(9Z))326
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/18:1(9Z)/19:0cycw7)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/16:0)323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/18:1(9Z))323
Phospholipid Biosynthesis CL(16:0/18:1(9Z)/19:0cycw7/19:0cycw7)323

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (75.00)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.90 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]